Edward Hughes
Edward F.X. Hughes

STRATEGY
Professor of Strategy
Professor of Preventive Medicine, Feinberg School of Medicine (Courtesy)

Print Overview

Professor Hughes, a physician, came to Kellogg from the National Bureau of Economic Research and Mt. Sinai School of Medicine in the City of New York. A graduate of the Harvard Medical School and Columbia University School of Public Health, he originally trained in General Surgery at Columbia-Presbyterian Medical Center, also in the City of New York.

In addition to his responsibilities at Kellogg, Dr. Hughes founded the University's Center for Health Services and Policy Research (now the Institute for Health Policy Studies) and served as its Director for seventeen years. He also served as the Director of Kellogg's Health Enterprise Management Program and is the founder of Kellogg's joint MD-MBA Degree Program. Professor Hughes has played a central role in the development of the Pharmaceutical/Biotechnology/Medical Device curriculum at Kellogg and for many years served as Co-Director of the Biotechnology Program.

Dr. Hughes serves as a member of Northwestern University's Faculty Senate and was recently elected to the position of Vice President/President Elect of the Senate. 

His research interests entail the pharmaceutical, biotechnology, and medical device industries; the efficient utilization of resources in healthcare; health policy and economics; managed care; and Leadership.

In addition to his teaching "Health Policy" and "Managerial Challenges in the Pharmaceutical, Biotechnology, and Medical Device Industries" in the Health Program, Professor Hughes teaches "Leadership," an elective course in the Management of Organizations Department. He is also a Professor of Preventive Medicine in the Feinberg School of Medicine.



Areas of Expertise
Policy (Biotechnology)
Healthcare Management
Hospital/Physician Relations
Managed Care Systems

  • Recent Media Coverage

    Bloomberg Daily Tax Report: Focus at Medtronic’s Transfer Pricing Trial Turns to Product Quality

    New York Times: WellPoint Sells Its Pharmacy Benefits Division

    Fortune: Will merger be Pfizer's miracle drug?

    New York Times: Pfizer Said to Be Closing In on Deal for Wyeth

    See all Kellogg in the Media
Print Vita
Education
MPH, 1969, Public Health, Columbia University
MD, 1966, Harvard University
BA, 1962, Philosophy, Amherst College

Academic Positions
Professor, Preventive Medicine, Feinberg School of Medicine, Northwestern University, 1977-present
Professor, Health Industry Management, Management, Kellogg School of Management, Northwestern University, 1977-present
Founder, Co-Chairman, Steering Committee, MD/MBA Joint Degree Program, Kellogg School of Management & The Feinberg School of Medicine, Northwestern University, 1986-1991
Director, Program in the Hospital and Health Services Management, Kellogg School of Management, Northwestern University, 1980-1983
Founder and Immediate Past Director, Center for Health Services and Policy Research, Northwestern University, 1977-1994
Acting Director, Health Economics, Community Medicine, Mount Sinai School of Medicine, City University of New York, 1974-1977
Lecturer, School of Social Work, Columbia University, 1972-1976
Director of Field Studies, Health Economics, Community Medicine, Mount Sinai School of Medicine, City University of New York, 1972-1977
Instructor-Associate Professor, Communitiy Medicine, Mount Sinai School of Medicine, City University of New York, 1969-1977

Grants and Awards
Elected President Elect/Vice-President, Faculty Senate, Northwestern University, 2014-17
Honorary Alumnus Award, Health Enterprise Management Program, Kellogg School of Management, 2011
Faculty Impact Award, 2009

Editorial Positions
Editorial Board, Journal of Health and Productivity Management, 2009-Present
Editorial Board, ManagedCare Interface, 1988-Present
Editorial Board Member, Journal of Clinical Outcomes

Print Research
Research Interests
Health policy; health management; managed care; physician behavior; physician-hospital relations; health delivery systems; economics and quality of health care; pharmaceutical, biotechnology, and medical device industries; leadership

Articles
Dranove, DavidEdward FX Hughes and Mark Shanley. 2003. Determinants of HMO Formulary Adoption Decisions. Health Services Research. 38(1): 169-190.
Shortell, Stephen M., Robert H. Jones, Alfred W. Rademaker, Robin R. Gillies, David DranoveEdward FX Hughes, Peter Budetti, Katherine S.E. Reynolds and Cheng-Fang Huang. 2000. Assessing the Impact of Total Quality Management and Organizational Culture on Mulitple Outcomes of Care for Coronary Artery Bypass Graft Surgery Patients. Medical Care. 38(2): 207-217.
Hughes, Edward FX and Stephen Shortell. 1988. The Effects of Regulation, Competition, and Ownership on Mortality Rates Among Hospital Inpatients. New England Economic Review. 318(17): 1100-1107.
Prince, Thomas REdward FX Hughes and Stanley R. Pliska. 1979. An Assessment of the Validity of the Results of HCFA's Demonstration and Evaluation Program for the Early and Periodic Screening, Diagnosis and Treatment Program (EPSDT): A metaevaluation. Center for Health Services and Policy Research.
Book Chapters
Gillies, Robin R., Katherine S.E. Reynolds, Stephen M. Shortell, Edward FX Hughes, Peter Budetti, Alfred W. Rademaker, Cheng-Fang Huang and David Dranove. 2000. "Implementing Continuous Quality Improvement." In The Quality Imperative: Measurement and Management of Quality in Healthcare, edited by John R. Kimberly and Etienne Minvielle, 79-102. London, UK: Imperial College Press.

 
Print Teaching
Teaching Interests
Health policy; health care industry; managed care; pharmaceutical, biotechnology, and medical device industries; leadership
Full-Time / Part-Time MBA
Health Policy (HEMA-441-0)
Health policy drives the American healthcare system. Every actor in the industry - whether one is working for a pharmaceutical, biotech or medical device firm, a provider or a payer - is affected by it. Health policy determines payment rates, access to technology, access to care and ultimately who lives or dies. Understanding the process of health policy-making in the United States and being able to influence that process are critical to the success of senior managers in our nation's health industry. This course establishes a conceptual framework for understanding health policy and the forces that shape it, details the health policy process so it can be understood and influenced, and examines in detail a number of critical health policy issues such as the Medicare drug benefit, the enhancement of access and the reimbursement for biotechnology products and medical devices. The highly interactive course features debates and panels, including some with leaders in healthcare policy.

Managerial Challenges in the Pharmaceutical, Biotech, and Medical Device Industries (HEMA-453-0)
This course provides an overview of the pharmaceutical, biotechnology and medical device industries. It explores their history, growth, organizational structure, vital statistics, recent performance, social contribution and prospects for the future. It examines the critical interrelationships between the firms within and across the three industries and the centrality of these interrelationships for product development and sales. Particular attention is placed on the regulation that impacts these industries and its implications for firm behavior, technological innovation, product development, adoption and costs, and marketing and sales strategies. Also addressed is the strategic management of firms in the three industries. The course is an elective for three majors: Health Industry Management, Biotechnology, and Technology and E-Commerce.

Perspectives on Leadership (KACI-467-0)